Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. AtriCure's Pre-Tax Income for the
three
months ended in Dec. 2024 was $-15.3 Mil. AtriCure's Revenue for the
three
months ended in Dec. 2024 was $124.3 Mil. Therefore, AtriCure's pretax margin for the quarter that ended in Dec. 2024 was -12.31%.
The historical rank and industry rank for AtriCure's Pretax Margin % or its related term are showing as below:
ATRC'
s Pretax Margin % Range Over the Past 10 Years
Min: -23.26 Med: -14.57 Max: 18.37
Current: -9.39
ATRC's Pretax Margin % is ranked worse than 58.36% of 819
companies
in the Medical Devices & Instruments industry
Industry Median: 0.66
vs ATRC: -9.39
AtriCure Pretax Margin % Historical Data
The historical data trend for AtriCure's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AtriCure's Pretax Margin %
For the Medical Instruments & Supplies subindustry, AtriCure's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AtriCure's Pretax Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where AtriCure's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AtriCure (NAS:ATRC) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
AtriCure Pretax Margin % Related Terms
Thank you for viewing the detailed overview of AtriCure's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATRC has been successfully added to your 